TABLE 1. Hepatitis B vaccine (HepB) schedule and estimated coverage* with a birth dose and third dose of HepB, by country — World Health Organization (WHO) South-East Asia Region, 2016–2019.
| Country/Area | No. of live births, 2019 | HepB schedule | Year HepB introduced | Year birth dose introduced | % Coverage |
|||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2016 |
2019 |
|||||||||
| HepB-BD | HepB3 | Districts† with ≥80% HepB3 coverage (%) | Timely HepB-BD§ | HepB3 | Districts† with ≥80% HepB3 coverage (%) | |||||
| Bangladesh | 3,408,614 | 6, 10, 14 wks | 2003 | ND | NA | 98 | 100 | NA | 98 | 98 |
| Bhutan | 11,496 | 0, 6, 10, 14 wks | 1997 | 2012 | 82 | 98 | 100 | 86 | 97 | 100 |
| Burma¶ | 981,223 | 0, 2, 4, 6 mos | 2003 | 2016 | NA | 90 | 88 | 17 | 90 | 84 |
| India | 27,192,790 | 0, 6, 10, 14 wks | 2002¶ | 2011 | 47 | 88 | 69 | 56 | 91 | 77 |
| Indonesia | 4,766,582 | 0, 2, 3, 4, 18 mos | 1997 | 2002 | NA | 84 | 74 | 84 | 85 | 77 |
| Maldives | 5,964 | 0, 2, 4, 6 mos | 1993 | 2000 | NA | 99 | 100 | 99 | 99 | 100 |
| Nepal | 640,789 | 6, 10, 14 wks | 2002 | ND | NA | 87 | 68 | NA | 93 | 69 |
| North Korea | 325,605 | 0, 6, 10, 14 wks | 2003 | 2004 | 98 | 96 | 100 | 98 | 97 | 100 |
| Sri Lanka | 329,754 | 2, 4, 6 mos | 2003 | ND | NA | 99 | 100 | NA | 99 | 100 |
| Thailand | 600,267 | 0, 2, 4, 6 mos** | 1992 | 1992 | NA | 99 | NR | 99 | 97 | 95 |
| Timor-Leste | 47,269 | 0, 6, 10, 14 wks | 2007 | 2016 | 42 | 79 | 100 | 70 | 83 | 54 |
| South-East Asia Region | 38,314,010 | — | — | — | 34 | 89 | — | 54 | 91 | — |
| Global | 139,677,000 | — | — | — | 35 | 84 | — | 43 | 85 | — |
Abbreviations: HepB-BD = birth dose of monovalent hepatitis B vaccine; HepB3 = third dose of hepatitis B containing vaccine; mos = months; NA = not applicable; ND = not done; NR = not reported; UNICEF = United Nations Children’s Fund; wks = weeks.
* WHO-United Nations Children’s Fund estimates. https://www.who.int/immunization/monitoring_surveillance/data/en/.
† For Maldives and Thailand, district-level HepB3 coverage data are provided for province and atolls only, respectively.
§ Timely hepatitis B birth-dose is defined as administration of a dose of hepatitis B vaccine within 24 hours of birth.
¶ HepB introduction was piloted in 2002 and made universal in 2011. https://extranet.who.int/iris/restricted/bitstream/handle/10665/329981/India2019_epi-eng.pdf?sequence=1&isAllowed=y.
** An additional HepB dose given at 1 month for infants born to a mother chronically infected with hepatitis B virus, in addition to birth dose and routine infant doses.